BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Blanco S, Salomé Konigheim B, Diaz A, Spinsanti L, Javier Aguilar J, Elisa Rivarola M, Beranek M, Collino C, MinSalCba Working Group, Fcm-Unc Working Group, Diaz M, Gabriela Barbás M, Mangeaud A, Verónica Gallego S. Evaluation of the Gam-COVID-Vac and vaccine-induced neutralizing response against SARS-CoV-2 lineage P.1 variant in an Argentinean cohort. Vaccine 2022;40:811-8. [PMID: 34953609 DOI: 10.1016/j.vaccine.2021.12.027] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Blanco S, Spinsanti L, Javier Aguilar J, Diaz A, Elisa Rivarola M, Beranek M, Fernández E, Mangeaud A, Salomé Konigheim B, Verónica Gallego S. Neutralizing response elicited by homologous and heterologous prime booster vaccination against ancestral SARS-CoV-2 B.1, P.1, C.37 and B.1.617.2 variants. Vaccine 2022;40:6706-10. [PMID: 36280564 DOI: 10.1016/j.vaccine.2022.10.021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Rak A, Donina S, Zabrodskaya Y, Rudenko L, Isakova-sivak I. Cross-Reactivity of SARS-CoV-2 Nucleocapsid-Binding Antibodies and Its Implication for COVID-19 Serology Tests. Viruses 2022;14:2041. [DOI: 10.3390/v14092041] [Reference Citation Analysis]
3 Marta RA, Nakamura GEK, de Matos Aquino B, Bignardi PR. COVID-19 vaccines: Update of the vaccines in use and under development. Vacunas (English Edition) 2022;23:S88-S102. [DOI: 10.1016/j.vacune.2022.11.007] [Reference Citation Analysis]
4 Marta RA, Nakamura GEK, de Matos Aquino B, Bignardi PR. COVID-19 vaccines: Update of the vaccines in use and under development. Vacunas 2022. [DOI: 10.1016/j.vacun.2022.06.003] [Cited by in F6Publishing: 2] [Reference Citation Analysis]